EDGAR Filing Documents for 0000898432-07-000996

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000898432-07-000996

Filing Date

2007-11-21

Accepted

2007-11-21 17:16:58

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.INVESTMENTS 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		sc-13g.htm	SC 13G	95028
2	EXHIBIT 1	exhibit_99.htm	EX-99	12946
	Complete submission text file	0000898432-07-000996.txt		110062

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address

Business Address PARC CLUB DU MOULIN A VENT 33 AVE DU DOCTEUR GEORGES LEVY VENISSIEUX CED I0 69693 2126641666

FLAMEL TECHNOLOGIES SA (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50223 | Film No.: 071263957
SIC: 2834 Pharmaceutical Preparations